Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-week Phase IIa AZD1236 trial in moderate to severe COPD
2008-002230-30Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AZD1236 oral tablet with Placebo oral tablet (2 arms). Primary endpoint: Safety and tolerability of AZD1236. Started May 2008; status: completed.
02
Drugs
AZD1236
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-002230-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002230-30.